At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02591 INNOGEN-B
Not Yet Opened 09-03 16:08:21
3.600
+0.075
+2.13%
High3.615Low3.460Vol11.07M
Open3.550D1 Closing3.525Amplitude4.40%
Mkt Cap1.65BTradable Cap1.51BTotal Shares457.00M
T/O39.39MT/O Rate2.63%Tradable Shares420.29M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
INNOGEN-B: Li Huang Disposes of Shares, Long Position Falls to 6.95%
HK Disclosure  ·  09-03 17:33
INNOGEN-B: Li Huang Disposes of Shares, Long Position Falls to 6.95%
INNOGEN-B: Cowin Capital Investment III Limited Disposes of Shares, Long Position Falls to 4.91%
HK Disclosure  ·  08-28
INNOGEN-B: Cowin Capital Investment III Limited Disposes of Shares, Long Position Falls to 4.91%
INNOGEN-B: Cowin Capital Investment Limited Disposes of Shares, Long Position Falls to 4.91%
HK Disclosure  ·  08-28
INNOGEN-B: Cowin Capital Investment Limited Disposes of Shares, Long Position Falls to 4.91%
INNOGEN-B: Cowin Capital Investment II LTD Disposes of Shares, Long Position Falls to 4.91%
HK Disclosure  ·  08-28
INNOGEN-B: Cowin Capital Investment II LTD Disposes of Shares, Long Position Falls to 4.91%
INNOGEN-B: Cowin China Growth Fund II, L.P. Disposes of Shares, Long Position Falls to 4.91%
HK Disclosure  ·  08-28
INNOGEN-B: Cowin China Growth Fund II, L.P. Disposes of Shares, Long Position Falls to 4.91%
Guangzhou Innogen (SEHK:2591) Stock Price Sinks As Losses Keep Funding Risks Alive
Simply Wall St.  ·  08-26
Guangzhou Innogen (SEHK:2591) Stock Price Sinks As Losses Keep Funding Risks Alive
INNOGEN-B: KOREA INVESTMENT HOLDINGS Co., Ltd. Disposes of Shares, Long Position Falls to 7.79%
HK Disclosure  ·  08-26
INNOGEN-B: KOREA INVESTMENT HOLDINGS Co., Ltd. Disposes of Shares, Long Position Falls to 7.79%
Guangzhou Innogen Pharmaceutical Group Co - Announces Intention to Repurchase H Shares up to HK$50 Mln On-Market
THOMSON REUTERS  ·  08-26
Guangzhou Innogen Pharmaceutical Group Co - Announces Intention to Repurchase H Shares up to HK$50 Mln On-Market
INNOGEN-B (02591) Posts Interim Net Loss of RMB 115 Million, Narrowing 5.72% Year-on-Year
Stock News  ·  08-25
INNOGEN-B (02591) Posts Interim Net Loss of RMB 115 Million, Narrowing 5.72% Year-on-Year
Guangzhou Innogen Pharmaceutical Posts HY LOSS of Rmb115.5 MLN​
Reuters  ·  08-25
Guangzhou Innogen Pharmaceutical Posts HY LOSS of Rmb115.5 MLN​
Guangzhou Innogen Pharmaceutical - ‍Hy Loss Rmb115.5 Mln​
THOMSON REUTERS  ·  08-25
Guangzhou Innogen Pharmaceutical - ‍Hy Loss Rmb115.5 Mln​
Guangzhou Innogen Pharmaceutical Group Co Ltd - ‍Hy REV Rmb78.2 Mln​
THOMSON REUTERS  ·  08-25
Guangzhou Innogen Pharmaceutical Group Co Ltd - ‍Hy REV Rmb78.2 Mln​
Guangzhou Innogen FY26 H1 Net Loss Narrows to RMB 115.46 Million; Revenue Rises 38.57% to RMB 78.22 Million
Reuters  ·  08-25
Guangzhou Innogen FY26 H1 Net Loss Narrows to RMB 115.46 Million; Revenue Rises 38.57% to RMB 78.22 Million
Cowin China Growth Fund II Trims Stake in INNOGEN-B With HK$3.73 Million Share Sale
Stock News  ·  08-21
Cowin China Growth Fund II Trims Stake in INNOGEN-B With HK$3.73 Million Share Sale
INNOGEN-B: Cowin Capital Investment III Limited Disposes of Shares, Long Position Falls to 5.75%
HK Disclosure  ·  08-21
INNOGEN-B: Cowin Capital Investment III Limited Disposes of Shares, Long Position Falls to 5.75%
INNOGEN-B: Cowin Capital Investment Limited Disposes of Shares, Long Position Falls to 5.75%
HK Disclosure  ·  08-21
INNOGEN-B: Cowin Capital Investment Limited Disposes of Shares, Long Position Falls to 5.75%
INNOGEN-B: Cowin China Growth Fund II, L.P. Disposes of Shares, Long Position Falls to 5.75%
HK Disclosure  ·  08-21
INNOGEN-B: Cowin China Growth Fund II, L.P. Disposes of Shares, Long Position Falls to 5.75%
INNOGEN-B: Weihe Zheng Disposes of Shares, Long Position Falls to 8.92%
HK Disclosure  ·  08-21
INNOGEN-B: Weihe Zheng Disposes of Shares, Long Position Falls to 8.92%
INNOGEN-B: Cowin Capital Investment II LTD Disposes of Shares, Long Position Falls to 5.75%
HK Disclosure  ·  08-21
INNOGEN-B: Cowin Capital Investment II LTD Disposes of Shares, Long Position Falls to 5.75%
Huang Li Reduces Stake in INNOGEN-B (02591) by 1.12 Million Shares at Approximately HK$4.34 Each
Stock News  ·  08-20
Huang Li Reduces Stake in INNOGEN-B (02591) by 1.12 Million Shares at Approximately HK$4.34 Each
No data available

Introduction

Company Name.
INNOGEN-B
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
Guangzhou Innogen Pharmaceutical Group Co Ltd is a China-based investment holding company principally engaged in the research, development and commercialisation of pharmaceutical products. The Company is primarily engaged in the commercialization of innovative, humanized, long-acting glucagon-like peptide-1 (GLP-1) receptor agonist. The Company is dedicated to developing therapies for diabetes and other metabolic diseases. The Company’s core product, Efsubaglutide Alfa (brand name: Diabegone), is used for the treatment of type 2 diabetes (T2D). The Company’s primary pipeline drug candidates include YN014, YN401, YN209, YN203, and YN202. The Company principally conducts its businesses in the domestic market.
Issue price:
--